Advanced search

Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer.

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Bracke, Marc, Herman Depypere, Tom Boterberg, Veerle Van Marck, KM VENNEKENS, E VANLUCHENE, M NUYTINCK, Rudolphe Serreyn, and Marcus Mareel. 1999. “Influence of Tangeretin on Tamoxifen’s Therapeutic Benefit in Mammary Cancer.” Journal of the National Cancer Institute 91 (4): 354–359.
APA
Bracke, Marc, Depypere, H., Boterberg, T., Van Marck, V., VENNEKENS, K., VANLUCHENE, E., NUYTINCK, M., et al. (1999). Influence of tangeretin on tamoxifen’s therapeutic benefit in mammary cancer. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 91(4), 354–359.
Vancouver
1.
Bracke M, Depypere H, Boterberg T, Van Marck V, VENNEKENS K, VANLUCHENE E, et al. Influence of tangeretin on tamoxifen’s therapeutic benefit in mammary cancer. JOURNAL OF THE NATIONAL CANCER INSTITUTE. 1999;91(4):354–9.
MLA
Bracke, Marc, Herman Depypere, Tom Boterberg, et al. “Influence of Tangeretin on Tamoxifen’s Therapeutic Benefit in Mammary Cancer.” JOURNAL OF THE NATIONAL CANCER INSTITUTE 91.4 (1999): 354–359. Print.
@article{116047,
  author       = {Bracke, Marc and Depypere, Herman and Boterberg, Tom and Van Marck, Veerle and VENNEKENS, KM and VANLUCHENE, E and NUYTINCK, M and Serreyn, Rudolphe and Mareel, Marcus},
  issn         = {0027-8874},
  journal      = {JOURNAL OF THE NATIONAL CANCER INSTITUTE},
  language     = {eng},
  number       = {4},
  pages        = {354--359},
  title        = {Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer.},
  volume       = {91},
  year         = {1999},
}

Web of Science
Times cited: